According to the latest report by IMARC Group, titled “Global Liquid Biopsy Market Size, Share, Industry Trends, Research Report, Growth, Opportunity and Forecast 2022-2027“, the global liquid biopsy market reached a value of US$ 1.49 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.7 Billion by 2027 exhibiting a CAGR of 15.70% during 2022-2027.
Liquid biopsy is the non-invasive sampling and analysis of liquid state biological tissue, enabling doctors to obtain information about diseases like cancer and tumors. This technique can reflect the changes in gene expression profile and provide a robust base for individualized therapy. It is used for monitoring and diagnosing diseases through advanced procedures like human genome sequencing. Liquid biopsy is a fast, convenient and reproducible sampling method that facilitates the early screening of cancer, monitors progression, accesses therapeutic response and clinical prognosis, and detects recurrent and refractory tumors.
|Base Year: 2021|
|Forecast Year: 2022-2027|
Liquid Biopsy Market Trends and Drivers:
Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth.
Get a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/liquid-biopsy-market/requestsample
In addition, the rising prevalence of cancer due to environmental factors, tobacco consumption, Hepatitis B and C, and lifestyle changes is also escalating the demand for liquid biopsy. Besides this, liquid biopsy is also widely adopted as this technique detects epidermal growth factor receptor (EGFR) gene mutation among patients with non-small cell lung cancer (NSCLC).
Furthermore, technological advancements and extensive investments in research and development (R&D) activities to encourage the introduction of advanced cancer solutions are anticipated to positively influence the market growth in the upcoming years.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Liquid Biopsy Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of region, product and service, circulating biomarker, cancer type and end user.
Breakup by Product and Service:
- Kits and Reagents
- Platforms and Instruments
Breakup by Circulating Biomarker:
- Circulating Tumor Cells
- Extracellular Vesicles
- Circulating Tumor DNA
Breakup by Cancer Type:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
Breakup by End User:
- Hospitals and Laboratories
- Academic and Research Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/liquid-biopsy-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800